Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INVESTIGATIONAL PRODUCT for Immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 78 adverse event reports in the FDA FAERS database where INVESTIGATIONAL PRODUCT was used for Immunisation.

Most Reported Side Effects for INVESTIGATIONAL PRODUCT

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 241 4.5% 29 215
Pneumonia 229 4.3% 69 209
Acute kidney injury 198 3.7% 35 185
Pyrexia 189 3.5% 17 171
Anaemia 176 3.3% 21 151
Diarrhoea 170 3.2% 28 131
Sepsis 168 3.1% 66 147
Dyspnoea 156 2.9% 26 124
Nausea 134 2.5% 14 93
Hypotension 130 2.4% 22 116
Vomiting 128 2.4% 15 99
Neutropenia 126 2.3% 16 68
Dehydration 113 2.1% 8 103
Fatigue 111 2.1% 18 77
Death 102 1.9% 102 33

Other Indications for INVESTIGATIONAL PRODUCT

Non-small cell lung cancer (288) Acute myeloid leukaemia (210) Product used for unknown indication (197) Malignant melanoma (181) Breast cancer (168) Plasma cell myeloma (151) Chronic lymphocytic leukaemia (104) Cardiac failure chronic (103) Neoplasm (101) Chronic obstructive pulmonary disease (89)

Other Drugs Used for Immunisation

INFLUENZA VIRUS VACCINE (560) PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (281) COVID-19 VACCINE NOS (269) TOZINAMERAN (207) MEASLES VIRUS STRAIN ENDERS^ ATTENUATED EDMONSTON LIVE ANTIGEN\MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN\RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN (152) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (148) PNEUMOCOCCAL VACCINE POLYVALENT (140) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (123) AD26.COV2.S (113) STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A (111)

Related Pages

INVESTIGATIONAL PRODUCT Full Profile All Immunisation Drugs INVESTIGATIONAL PRODUCT Demographics INVESTIGATIONAL PRODUCT Timeline